key: cord-0966107-91w1o7xa authors: Liu, Qian; Shi, Yu; Cai, Jun; Duan, Yaqi; Wang, Rongshuai; Zhang, Hongyan; Ruan, Qiurong; Li, Jiansha; Zhao, Lei; Ping, Yifang; Chen, Rong; Ren, Liang; Fei, Xiaochun; Zhang, Heng; Tang, Rui; Wang, Xi; Luo, Tao; Liu, Xindong; Huang, Xuequan; Liu, Zhenhua; Ao, Qilin; Ren, Yong; Xiong, Jing; He, Zhicheng; Wu, Haibo; Fu, Wenjuan; Zhao, Pengnan; Chen, Xinwei; Qu, Guoqiang; Wang, Yunyun; Wang, Xi; Liu, Jia; Xiang, Dongfang; Xu, Sanpeng; Zhou, Xiaowei; Li, Qingrui; Ma, Jinghong; Li, Heng; Zhang, Jie; Huang, Sizhe; Yao, Xiaohong; Zhou, Yiwu; Wang, Chaofu; Zhang, Dingyu; Wang, Guoping; Liu, Liang; Bian, Xiu-Wu title: Pathological changes in the lungs and lymphatic organs of twelve COVID-19 autopsy cases date: 2020-09-29 journal: Natl Sci Rev DOI: 10.1093/nsr/nwaa247 sha: 3a0747bbb30e953b227fb93288cd7da13e35d88d doc_id: 966107 cord_uid: 91w1o7xa Systematic autopsy and comprehensive pathological analyses of COVID-19 decedents should provide insights into the disease characteristics and facilitate the development of novel therapeutics. In this study, we report the autopsy findings from the lungs and lymphatic organs of twelve COVID-19 decedents that evaluated histopathological changes, immune cell signature, and inflammatory factor expression in the lungs, spleen, and lymph nodes. Here we show that the major pulmonary alternations included diffuse alveolar damage, interstitial fibrosis, and exudative inflammation featured with extensive serous and fibrin exudates, macrophage infiltration, and abundant production of inflammatory factors (IL-6, IP-10, TNFα and IL-1β). The spleen and hilar lymph nodes contained lesions with tissue structure disruption and immune cell dysregulation, including lymphopenia and macrophage accumulation. These findings provide pathological evidence that links injuries of the lungs and lymphatic organs with the fatal systematic respiratory and immune malfunction in critically ill COVID-19 patients. Coronaviruses are non-segmented positive-sense RNA viruses that are constantly transmitted from animal to humans [1] . Although most coronaviruses cause mild respiratory diseases in human, the epidemics of severe acute respiratory syndrome associated coronavirus (SARS-CoV) and the Middle East respiratory syndrome-associated coronavirus (MERS-CoV) infected over 10,000 cumulative cases in the past two decades, with mortality rates of 10% for SARS-CoV and 37% for MERS-CoV [2, 3] . From the end of 2019, COVID-19, caused by a novel coronavirus SARS-CoV-2 has caused a global pandemic [2, 3] . Although COVID-19 is generally an acute self-limited disease featured with pneumonia, approximately 15% of COVID-19 patients, especially those with older age and pre-existing medical conditions, can rapidly develop fatal systematic conditions, such as acute respiratory distress syndrome and severe cardiovascular or renal injuries, among which 5%-6% cases may progress into critical status with high mortality [4, 5] . Thus , the virologic, epidemiological, and clinical characteristics of COVID-19 has been extensively investigated and the clinical features profiled. However, COVID-19-associated pathological alterations and the underlying translational relevance remain to be elucidated. Recent investigations through full autopsy or minimally invasive autopsy of COVID-19 decedents by us and other laboratories [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] , revealed that SARS-CoV-2 hijacked angiotensin converting enzyme 2 (ACE2) for entry into target cells [17] to cause severe pathologic changes in the lungs and multiple extrapulmonary organs/tissues. While clinical observations supported that most of the critically ill COVID-19 patients manifested severe immune disorders [4, 5] , which might result in damages of the lung and multiple extrapulmonary organs, the changes of immune cell signature in the lungs and lymphatic organs such as the spleen and lymph nodes have not been fully investigated. Table 1 . Macroscopic changes of the postmortem lungs included increased weight, focal bilateral consolidation, and peripheral pulmonary bullae formation ( Fig. 1A-1B) , which were often overlaid by chronic diseases. Additionally, the trachea and bronchus contained mucosa congestion and increased secretion ( Fig. 1C) . Ten of the 12 autopsy cases (83.3%) were seen with mild pleural effusion and pleural adhesion. The major pulmonary microscopic features were summarized in Table 2 . All 12 autopsy specimens manifested diffuse alveolar damage with moderate to extensive pneumocyte desquamation and hyperplasia (Fig. 1D) , but virus inclusion body was rarely identified (Fig. 1E) . The alveolar space was filled with protein-rich exudation, fibrous organization ( Fig. 1F-1H) , and hyaline membrane structure (10/12 [83.3%]) (Fig. 1I) . Squamous metaplasia (7/12 [58.3%]) was found in terminal bronchioles (Fig. 1J) . In some areas, there was mild to severe interstitial fibrosis ( Fig. 1K) with different extent of inflammatory cell infiltration. Microscopic features of pulmonary vessels included vasculitis (Fig. 1L) , mixed thrombi in small vessels (Fig. 1M) , and hyaline thrombi in capillaries, alongside hemorrhagic necrosis (Fig. 1N ) and focal hemorrhage (Fig. 1O) . Dilatation of bronchioles with focal mucous epithelial desquamation and mucous exudation were detected in all 12 autopsy lungs (Fig. 1P ). Focal to extensive pulmonary abscess ( Immunohistochemical staining showed SARS-CoV-2 spike protein located in alveolar and bronchial epithelia from lungs of COVID-19 cases, but not in control pulmonary tissues from a patient died of heart attack ( Fig. 2A-2B ). Serial sectioning further demonstrated that SARS-CoV-2 spike protein and ACE2 were co-expressed in alveolar and bronchial epithelia of the COVID-19 cases ( Fig. 2A-2B ), confirming that ACE2-expressing epithelial cells could be the target of SARS-CoV-2 in the lungs. Investigation of pulmonary immune cell signature showed that in contrast with the minor infiltration of patients, implying that acute respiratory distress syndrome, multiple organ injuries, comorbidities like immune disorders and coagulation disorders, as well as underlying diseases could contribute to the mortality of COVID-19 patients [8-11, 13, 14, 16, 18-20] . In addition, most of the cases in our cohort were deceased elder patients comparable to published COVID-19 biopsy/autopsy reports [10, 16] . Comorbidities in our cohort were also consistent with clinical observational studies [21] . Thus, the corroboration of pathological findings with analyses of the serological and clinical data enables a better evaluation of COVID-19 disease progression and outcome. A recent study confirmed that SARS-CoV-2 uses coronavirus spike glycoproteins to bind ACE2 for cell entry [22] . Our findings revealed a close association between SARS-CoV-2 infection and ACE2 specimens, suggesting that macrophage-mediated phagocytosis may contribute to lymphopenia; 2) The increase of pro-inflammatory factors, which has been implicated to disrupt the maintenance and proliferation of lymphocytes, is a common event during COVID-19 progression [23, 24] . The use of glucocorticoid in COVID-19 patients may cause immune-suppression and lymphocyte reduction. In contract with the reduced proportion of lymphocytes, the proportion of macrophages was significantly increased in alveolar space and the spleen, frequently observed in COVID-19 autopsy cases [18] . These results provide pathological evidence for the development of therapeutics aimed at promoting lymphopoiesis and neutralizing pro-inflammatory signals to prevent cytokine storm in severe COVID-19 patients. The autopsy cases in this study were the first consecutive 12 cases from Jinyintan Hospital, Wuhan, China. All decedents met the diagnostic criteria for COVID-19 and the presence of SARS-CoV-2 in all autopsy cases was confirmed by PCR tests. Basic patient information and clinical data were obtained from electronic medical records from Jinyintan Hospital, Wuhan, China as summarized in Table 1 . Pulmonary tissues from a patient died from sudden heart death were used as control specimens for All statistical analyses were performed using SPSS (Statistical Package for the Social Sciences) version 13.0 software (SPSS Inc). Categorical variables were described as frequency rates and percentages. Continuous variables were described using the mean and median values. The means for continuous variables were compared using independent group t tests when the data was normally distributed. For unadjusted comparisons, a 2-sided α of less than .05 was considered statistically significant. Origin and evolution of pathogenic coronaviruses Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia Identification of a novel coronavirus in patients with severe acute respiratory syndrome Clinical features of patients infected with 2019 novel coronavirus in Wuhan Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China Pathological findings of COVID-19 associated with acute respiratory distress syndrome Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer A pathological report of three COVID-19 cases by minimal invasive autopsies Pathological evidence for residual SARS-CoV-2 in pulmonary tissues of a ready-for-discharge patient Post-mortem examination of COVID19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings of lungs and other organs suggesting vascular dysfunction COVID-19 autopsies Autopsy findings and venous thromboembolism in patients with COVID-19 Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive Multiorgan and renal tropism of SARS-CoV-2 Postmortem examination of patients with COVID-19 Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients Autopsy of COVID-19 victims in China Gross examination report of a COVID-19 death autopsy Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein Cytokines: promoters and dampeners of autoimmunity Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic Society of Pathological Doctors Chinese Medical Doctors Association Chinese Society of Pathology and Chinese Medical Association. Provisional guidelines on autopsy practice for deaths